Literature DB >> 33775738

Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.

Yaping Xue1, Celeste Chidiac1, Yann Herault2, Claire Gaveriaux-Ruff1.   

Abstract

The two voltage gated sodium channels Nav1.7 and Nav1.8 are expressed in the peripheral nervous system and involved in various pain conditions including inflammatory and neuropathic pain. Rodent models bearing deletions or mutations of the corresponding genes, Scn9a and Scn10a, were created in order to understand the role of these channels in the pathophysiological mechanism underlying pain symptoms. This review summarizes the pain behavior profiles reported in Scn9a and Scn10a rodent models. The complete loss-of-function or knockout (KO) of Scn9a or Scn10a and the conditional KO (cKO) of Scn9a in specific cell populations were shown to decrease sensitivity to various pain stimuli. The Possum mutant mice bearing a dominant hypermorphic mutation in Scn10a revealed higher sensitivity to noxious stimuli. Several gain-of-function mutations were identified in patients with painful small fiber neuropathy. Future knowledge obtained from preclinical models bearing these mutations will allow understanding how these mutations affect pain. In addition, the review gives perspectives for creating models that better mimic patients' pain symptoms in view to developing novel analgesic strategies.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Knockout; Mutant; Nav1.7; Nav1.8; Neuropathic pain; Pain behavior; Rodent model; SCN10A; SCN9A

Year:  2021        PMID: 33775738     DOI: 10.1016/j.neulet.2021.135844

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  5-Oxopyrrolidine-3-carboxamides as Nav1.8 Inhibitors for Treating Pain Disorders, Cough Disorders, and Acute and Chronic Itch Disorders.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-04-14       Impact factor: 4.345

2.  2-Oxooxazolidine-5-carboxamides as Nav1.8 Inhibitors for Treating Pain Disorders, Cough Disorders, and Acute and Chronic Itch Disorders.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-03-01       Impact factor: 4.345

3.  The Human SCN9A R185H Point Mutation Induces Pain Hypersensitivity and Spontaneous Pain in Mice.

Authors:  Yaping Xue; Mélanie Kremer; Maria Del Mar Muniz Moreno; Celeste Chidiac; Romain Lorentz; Marie-Christine Birling; Michel Barrot; Yann Herault; Claire Gaveriaux-Ruff
Journal:  Front Mol Neurosci       Date:  2022-06-13       Impact factor: 6.261

4.  The Human SCN10AG1662S Point Mutation Established in Mice Impacts on Mechanical, Heat, and Cool Sensitivity.

Authors:  Celeste Chidiac; Yaping Xue; Maria Del Mar Muniz Moreno; Ameer Abu Bakr Rasheed; Romain Lorentz; Marie-Christine Birling; Claire Gaveriaux-Ruff; Yann Herault
Journal:  Front Pharmacol       Date:  2021-12-01       Impact factor: 5.810

5.  Analgesia effect of lentivirus-siSCN9A infected neurons in vincristine induced neuropathic pain rats.

Authors:  Baojun Fu; Rong Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Selective optogenetic activation of NaV1.7-expressing afferents in NaV1.7-ChR2 mice induces nocifensive behavior without affecting responses to mechanical and thermal stimuli.

Authors:  Toyoaki Maruta; Kotaro Hidaka; Satoshi Kouroki; Tomohiro Koshida; Mio Kurogi; Yohko Kage; Seiya Mizuno; Tetsuro Shirasaka; Toshihiko Yanagita; Satoru Takahashi; Ryu Takeya; Isao Tsuneyoshi
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.